Intravenous

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Dutton Associates Announces Investment Opinion: Vyteris Rating Speculative Buy In Update By Dutton Associates

Published September 8, 2008, 8:39 am, Centre Daily Times

Dutton Associates updates its coverage of Vyteris (OTCBB:VYTR) maintaining a Speculative Buy rating and a $1 price target. The 13-page report by Dutton senior analyst Richard W. West, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, FactSet, Capital IQ, Zacks, Reuters, Knobias, and other leading financial portals.

Discover News | Full Story


Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in ...

Published September 8, 2008, 8:10 am, PR Newswire via Yahoo! Finance

Oncolytics Biotech Inc. announced today that that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers.

Discover News | Full Story


State studying hospital-contracted infections

Published September 8, 2008, 8:04 am, The Farmington Daily Times

FARMINGTON — San Juan Regional Medical Center is one of six hospitals statewide that are participating in the state Department of Health's healthcare-associated infection pilot project.

Discover News | Full Story


Dutton Associates Announces Investment Opinion: Vyteris Rating Speculative Buy In Update By Dutton Associates

Published September 8, 2008, 7:30 am, Business Wire via Yahoo! Finance

ROSEVILLE, Calif.----Dutton Associates updates its coverage of Vyteris maintaining a Speculative Buy rating and a $1 price target. The 13-page report by Dutton senior analyst Richard W.

Discover News | Full Story


Positive SPA Reply From The FDA For TopoTarget's Pivotal Trial With Belinostat In PTCL

Published September 8, 2008, 7:14 am, Medical News Today

TopoTarget A/S (OMX: TOPO) announced that a positive reply from the FDA was received on a Special Protocol Assessment (SPA) for a phase III trial for belinostat in PTCL (Peripheral T-Celle Lymphoma). This pivotal trial is to enrol approximately 120 patients and is to begin in Q4 2008.

Discover News | Full Story


Phase II Results Of COL-144 Presented At European Headache And Migraine Trust International Congress 2008

Published September 8, 2008, 6:14 am, Medical News Today

CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.

Discover News | Full Story


Patients At Risk From Hospital Tubes

Published September 8, 2008, 6:14 am, Medical News Today

A third of patients have unnecessary tubes (cannulae) inserted when they are in hospital, needlessly exposing them to serious complications such as infection and blood clots, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

Discover News | Full Story


Shedding Light On Bowel Cancer

Published September 8, 2008, 6:14 am, Medical News Today

An effective new method of diagnosing bowel (also known as colorectal, or large bowel) cancer using 'light' may soon be available, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

Discover News | Full Story


FivePrime Initiates Phase I Clinical Trial of FP-1039 in Patients With Advanced Cancers

Published September 8, 2008, 6:05 am, Business Wire via Yahoo! Finance

SAN FRANCISCO----Five Prime Therapeutics, Inc. today announced the first patient has been enrolled in a Phase I clinical trial of its investigational protein therapeutic, FP-1039, in patients with advanced solid tumors.

Discover News | Full Story


Mo Twister finally speaks up about true condition of his daughter

Published September 8, 2008, 5:16 am, PEP

Mo Twister finally speaks up about his daughter's true condition, dismissing reports that his daughter with Bunny Paras, Moira, has brain cancer. Interviewed by Showbiz Central co-host Pia Guanio yesterday, September 7, Mo expressed mixed emotions of disappointment, hope, and joy.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a